Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accessible, ambulant, CDK, cured, dedication, default, delandistrogene, draft, flexibility, foreclosure, fundraising, incomplete, inquiry, insolvency, Italfarmaco, length, moxeparvovec, ninety, NovaQuest, outpace, partnership, penalize, prepay, prepayment, refund, relinquish, RIFA, stipulation, summary, waived, Yen
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view